Life insurance and HIV antibody testing.

Por Barton, S., Roth, P.
Publicado em 1992

Colony-stimulating factor 1 in the human response to neonatal listeriosis.

Por Grieg, A, Roth, P
Publicado em 1995

Double-blind evaluation of the safety and hypnotic efficacy of temazepam in insomniac outpatients

Por Heffron, W. A., Roth, P.
Publicado em 1979

Total intravenous anesthesia with propofol for thymectomy in a patient with myasthenia gravis.

Por Roelofse, J. A., Roth, P. J.
Publicado em 1993

Disulphide-linked receptors for IgE on rat basophilic leukaemia cells.

Por Roth, P A, Rao, M, Froese, A
Publicado em 1986

Effects of vitamin E supplementation during erythropoietin treatment of the anaemia of prematurity

Por Pathak, A, Roth, P, Piscitelli, J, Johnson, L
Publicado em 2003

Integrin inhibition promotes atypical anoikis in glioma cells

Por Silginer, M, Weller, M, Ziegler, U, Roth, P
Publicado em 2014

OS09.3 Synergistic activity of NKG2D-based chimeric antigen receptor (CAR)-T cells and radiotherapy against glioma

Por Weiss, T., Weller, M., Pruschy, M., Sentman, C., Roth, P.
Publicado no Neuro Oncol (2017)

P08.48 Therapeutic targeting of TGF- β(1/2) in experimental gliomas

Por Papachristodoulou, A., Weller, M., Hasenbach, K., Janicot, M., Roth, P.
Publicado no Neuro Oncol (2017)

P08.56 Autocrine activation of the IFN signaling pathway modulates the immunogenicity of glioma cells

Por Silginer, M., Nagy, S., Happold, C., Schneider, H., Weller, M., Roth, P.
Publicado no Neuro Oncol (2017)

P02.07 INTERFERON-β MODULATES THE INNATE IMMUNE RESPONSE AGAINST GLIOBLASTOMA INITIATING CELLS

Por Wolpert, F., Happold, C., Roth, P., Reifenberger, G., Weller, M., Eisele, G.
Publicado em 2014

Evaluation of methods for detecting human papillomavirus deoxyribonucleotide sequences in clinical specimens.

Por Caussy, D, Orr, W, Daya, A D, Roth, P, Reeves, W, Rawls, W
Publicado em 1988

Genetic and molecular complexity of the position effect variegation modifier mod(mdg4) in Drosophila.

Por Büchner, K, Roth, P, Schotta, G, Krauss, V, Saumweber, H, Reuter, G, Dorn, R
Publicado em 2000

P02.04 MICRORNA-MEDIATED DOWN-REGULATION OF NKG2D LIGAND EXPRESSION REDUCES GLIOMA CELL IMMUNOGENICITY

Por Codo, P., Weller, M., Meister, G., Szabo, E., Steinle, A., Wolter, M., Reifenberger, G., Roth, P.
Publicado em 2014

OS01.6 Glioblastoma in the era of bevacizumab: an epidemiological study in the Canton of Zurich, Switzerland

Por Gramatzki, D., Roth, P., Rushing, E. J., Weller, J., Andratschke, N., Hofer, S., Regli, L., Oberle, J., Rohrmann, S., Weller, M.
Publicado no Neuro Oncol (2017)

P01.30 In vivo effects of isoform-specific inhibition of TGF-β(3) in glioblastoma

Por Seystahl, K., Burghardt, I., Gramatzki, D., Schneider, H., Papachristodoulou, A., Hasenbach, K., Frei, K., Janicot, M., Roth, P., Weller, M.
Publicado no Neuro Oncol (2017)

Case Report of Exposure to Voriconazole in the Second and Third Trimesters of Pregnancy

Por Shoai Tehrani, M., Sicre de Fontbrune, F., Roth, P., Allisy, C., Bougnoux, M.-E., Hermine, O., Lecuit, M., Lortholary, O., Charlier, C.
Publicado em 2013